Epr Gene Technologies Private Limited

Epr Gene Technologies Private Limited — pharma in Hyderabad, Telangana, India. FY 2026 financials and compliance.
CIN U72200TG2006PTC051816 Incorporated 27 November 2006 ROC Hyderabad HQ Hyderabad, Telangana, India
Struck Off Private Limited Company pharma
Data last updated
Revenue · FY 2020
₹3.22 Lakh
▼ 52.43% YoY
EBITDA · FY 2020
*****
▼ 435.17% YoY
Net profit · FY 2020
*****
▼ 837.99% YoY
Authorised capital
₹1.5 Cr
Registered with MCA
Paid-up capital
₹1.5 Cr
Issued & subscribed
Open charges
None
Satisfied ₹2.7 Cr
Company age
20 yrs
Est. 2006
Last financials
Mar 2023
Balance sheet date

About Epr Gene Technologies Private Limited

Data last updated: 21 July 2025

Epr Gene Technologies Private Limited was a private limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Epr Pharmaceuticals Private Limited. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It specialised in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 27 November 2006.

Registered with ROC Hyderabad under CIN U72200TG2006PTC051816.

Capital: an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.5 Cr. It was led by directors Onteddu Devi Nirmala and Markandeya Gorantla.

Last AGM: 30 September 2023. Financial statements filed for year ended 31 March 2023. Office: Plot-557 Road No.31 Jubilee Hills, Hyderabad, Telangana, India – 500033.

As per the financials filed for FY 2020, the company reported a revenue of ₹3.22 Lakh, a decline of 52.43% compared to the previous year.

It operated as a subsidiary of Epr Pharmaceuticals Private Limited.

As per MCA filings, the company had satisfied charges of ₹2.7 Cr on record.

The company is no longer operational and has been struck off from the Register of Companies, typically due to non-filing of annual returns or failure to commence business. Entering into any agreement with a struck-off entity carries significant legal and financial risk.

Company Details of Epr Gene Technologies Private Limited
CIN U72200TG2006PTC051816
Registration Number 051816
Incorporation Date 27 November 2006
ROC Hyderabad
Listing Status Unlisted
Company Status Struck Off
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Parent Company Epr Pharmaceuticals Private Limited
Compliance Status Active Compliant
Key People
Onteddu Devi Nirmala Director Markandeya Gorantla Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    Plot-557 Road No.31 Jubilee Hills, Hyderabad, Telangana, India – 500033
  • Industry
    Pharma, Pharma Contract R&D
Company report
Epr Gene Technologies Private Limited — full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Epr Gene Technologies Private Limited report

Financials, compliance, directors, charges, ownership and filings for Epr Gene Technologies Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Epr Gene Technologies Private Limited

Epr Gene Technologies Private Limited has one previous CIN (Corporate Identification Number): U72200AP2006PTC051816. The current CIN is U72200TG2006PTC051816, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U72200TG2006PTC051816 Current
U72200AP2006PTC051816 Previous

Business Activity of Epr Gene Technologies Private Limited

Epr Gene Technologies Private Limited operates primarily in the professional, scientific and technical sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
********* Professional, Scientific and Technical ********* Scientific research and development *********

Auditor Details of Epr Gene Technologies Private Limited

Epr Gene Technologies Private Limited is audited by CH & ASSOCIATES for the financial year 2019. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
CH & ASSOCIATES blur-value blur-value blur-value

Board of Directors of Epr Gene Technologies Private Limited

Epr Gene Technologies Private Limited is currently managed by 2 directors, with 4 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Directors (as last reported)
Name Designation Appointment Date Tenure Status
Onteddu Devi Nirmala
Also directs: Npp Bagh-Bagicha Llp
Director 27 Nov 2006 19 Years 7 Months As last reported
Markandeya Gorantla
Also directs: Green Habitat Holdings Llp, Dr Gorantla Llp, Wt Faba Biocatalyst Llp and 5 more
Director 10 Jul 2015 10 Years 11 Months As last reported
View all directors

Financials of Epr Gene Technologies Private Limited FY 2023 filings available

Epr Gene Technologies Private Limited reported revenue of ₹- (down -52.43% YoY) for FY 2020. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
- ▼ -52.43%
Profit
***** ▼ -837.99%
EBITDA
***** ▼ -435.17%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated — Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Epr Gene Technologies Private Limited

As of FY 2019, Epr Gene Technologies Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Charges & Borrowings of Epr Gene Technologies Private Limited

Open charges
₹0
Satisfied charges
₹2.7 Cr
Breakdown by lending institutions
Karvy Financial Services Limited₹2.70 Cr
Latest charge details
DateLenderAmountStatus
02 Oct 2011 Karvy Financial Services Limited ₹2.7 Cr Satisfied

Total charge records: 1 View all charges

Employees and EPFO Compliance at Epr Gene Technologies Private Limited

View historical data on people associated with Epr Gene Technologies Private Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Epr Gene Technologies Private Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Epr Gene Technologies Private Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Epr Gene Technologies Private Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Epr Gene Technologies Private Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay — Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Epr Gene Technologies Private Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Epr Gene Technologies Private Limited

MSME Payment Delays by Epr Gene Technologies Private Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Epr Gene Technologies Private Limited

Subsidiaries & Group Companies of Epr Gene Technologies Private Limited

See the full corporate group — holding company, subsidiaries, associates and joint ventures of Epr Gene Technologies Private Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Epr Gene Technologies Private Limited

MCA Filings & Documents of Epr Gene Technologies Private Limited

Download official documents filed with the Ministry of Corporate Affairs — from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Epr Gene Technologies Private Limited

Activity
30 Sep 2023
Epr Gene Technologies Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Activity
31 Mar 2023
Epr Gene Technologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
Directors
10 Jul 2015
Markandeya Gorantla was appointed as a Director on 10 Jul 2015 & has been associated with this company since 10 years 11 months.
Charges
20 Aug 2014
A charge registered on 02 Oct 2011 via Charge ID 10319591 with Karvy Financial Services Limited was fully satisfied on 20 Aug 2014.
Charges
02 Oct 2011
A charge with Karvy Financial Services Limited amounted to Rs. 2.70 Cr with Charge ID 10319591 was registered on 02 Oct 2011.
Directors
27 Nov 2006
Onteddu Devi Nirmala was appointed as a Director on 27 Nov 2006 & has been associated with this company since 19 years 7 months.

Frequently Asked Questions about Epr Gene Technologies Private Limited

Epr Gene Technologies Private Limited has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Epr Gene Technologies Private Limited is a struck-off private limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 27 November 2006 and is registered under CIN U72200TG2006PTC051816. The company has been struck off by the Registrar of Companies and is no longer operational.

The current directors of Epr Gene Technologies Private Limited are:

The CIN (Corporate Identification Number) of Epr Gene Technologies Private Limited is U72200TG2006PTC051816. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The primary industry of Epr Gene Technologies Private Limited is pharma. The company specifically operates in pharma contract r and d. The company was active in this sector before being struck off.

The company has its registered office at Plot-557 Road No.31 Jubilee Hills, Hyderabad, Telangana, India – 500033.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding — sourced from MCA, SEBI and RBI filings.

Subscription plans available